Abstract

Dysphagia is a frequent complication in lung cancer patients, significantly impacting their nutritional intake, hydration status, and overall quality of life. Video-fluoroscopic swallow evaluation (VFSE) has emerged as a pivotal diagnostic and therapeutic tool in the management of dysphagia associated with lung cancer. This imaging technique utilizes real-time fluoroscopy to assess the swallowing function, providing detailed insights into oropharyngeal and esophageal phases. The diagnostic role of VFSE involves identifying specific swallowing impairments such as aspiration risk and guiding personalized treatment strategies. Therapeutically, VFSE facilitates the recommendation of targeted interventions, including swallow exercises and dietary modifications, aimed at improving swallowing function and minimizing aspiration risk. Repeat VFSE assessments enable clinicians to monitor treatment efficacy and adjust interventions accordingly. While VFSE involves radiation exposure, the benefits of accurate diagnostic information typically outweigh the associated risks when performed judiciously. Patient-centered care emphasizes education on safe swallowing practices and personalized dysphagia management plans tailored to individual patient needs. Looking forward, future research should explore advanced imaging techniques and personalized medicine approaches to further enhance VFSE’s role in optimizing dysphagia management in lung cancer patients. Ultimately, VFSE stands as a cornerstone in a multidisciplinary approach to dysphagia care, striving to improve outcomes and quality of life for individuals battling lung cancer.